KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $73.0 million.

  • Organon's Change in Accured Expenses rose 1406.25% to $73.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.0 million, marking a year-over-year decrease of 24750.0%. This contributed to the annual value of -$101.0 million for FY2024, which is 19901.96% down from last year.
  • Per Organon's latest filing, its Change in Accured Expenses stood at $73.0 million for Q3 2025, which was up 1406.25% from -$98.0 million recorded in Q2 2025.
  • Organon's 5-year Change in Accured Expenses high stood at $769.0 million for Q1 2021, and its period low was -$559.0 million during Q2 2021.
  • For the 5-year period, Organon's Change in Accured Expenses averaged around $27.2 million, with its median value being -$8.0 million (2022).
  • As far as peak fluctuations go, Organon's Change in Accured Expenses soared by 344347.83% in 2021, and later crashed by 95000.0% in 2023.
  • Quarter analysis of 5 years shows Organon's Change in Accured Expenses stood at -$57.0 million in 2021, then soared by 212.28% to $64.0 million in 2022, then rose by 6.25% to $68.0 million in 2023, then crashed by 207.35% to -$73.0 million in 2024, then surged by 200.0% to $73.0 million in 2025.
  • Its Change in Accured Expenses was $73.0 million in Q3 2025, compared to -$98.0 million in Q2 2025 and $39.0 million in Q1 2025.